Nearly all osteosarcomas are felt to have the RB1 pathway disrupted, some tumors accomplishing this with p16/INK4A silencing or CDK4/Cyclin D1 overexpression [36–38]. The gene discussed is CDKN2A; the disease is osteosarcoma.